M2-polarized and tumor-associated macrophages alter NK cell phenotype and function in a contact-dependent manner

Journal of Leukocyte Biology

Volumn 101, Issue 1, 2017, Pages 285-295

  Krneta, Tamara ^a   Gillgrass, Amy ^a   Poznanski, Sophie ^a   Chew, Marianne ^a   Lee, Amanda J ^a   Kolb, Martin ^b   Ashkar, Ali A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Cancer immunotherapy; Innate immunity; Tumor immunology

Indexed keywords

CD11B ANTIGEN; CD27 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW DERIVED MACROPHAGE; BREAST TUMOR; CELL ACTIVATION; CELL CONTACT; CELL ISOLATION; CELL VIABILITY; CELLS BY BODY ANATOMY; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; IN VITRO STUDY; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONEUM MACROPHAGE; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL COMMUNICATION; CELL POLARITY; CELL SURVIVAL; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD27; BONE MARROW CELLS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL POLARITY; CELL SURVIVAL; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; KILLER CELLS, NATURAL; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MACROPHAGES, PERITONEAL; MICE, INBRED C57BL; NEOPLASMS; PHENOTYPE; TRANSFORMING GROWTH FACTOR BETA;

EID: 85008426058     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3A1215-552R     Document Type: Article

References (36)

1. Srivastava, S., Lundqvist, A., Childs, R. W. (2008) Natural killer cell immunotherapy for cancer: a new hope. Cytotherapy 10, 775-783.
2. Bauernhofer, T., Kuss, I., Henderson, B., Baum, A. S., Whiteside, T. L. (2003) Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer. Eur. J. Immunol. 33, 119-124.
3. Platonova, S., Cherfils-Vicini, J., Damotte, D., Crozet, L., Vieillard, V., Validire, P., André, P., Dieu-Nosjean, M. C., Alifano, M., Régnard, J. F., Fridman, W. H., Sautès-Fridman, C., Cremer, I. (2011) Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. Cancer Res. 71, 5412-5422.
4. Gati, A., Da Rocha, S., Guerra, N., Escudier, B., Moretta, A., Chouaib, S., Angevin, E., Caignard, A. (2004) Analysis of the natural killer mediated immune response in metastatic renal cell carcinoma patients. Int. J. Cancer 109, 393-401.
5. Carrega, P., Morandi, B., Costa, R., Frumento, G., Forte, G., Altavilla, G., Ratto, G. B., Mingari, M. C., Moretta, L., Ferlazzo, G. (2008) Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD162 cells and display an impaired capability to kill tumor cells. Cancer 112, 863-875.
6. Levy, E. M., Roberti, M. P., Mordoh, J. (2011) Natural killer cells in human cancer: from biological functions to clinical applications. J. Biomed. Biotechnol. 2011, 676198.
7. Parkhurst, M. R., Riley, J. P., Dudley, M. E., Rosenberg, S. A. (2011) Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression. Clin. Cancer Res. 17, 6287-6297.
8. Solinas, G., Germano, G., Mantovani, A., Allavena, P. (2009) Tumorassociated macrophages (TAM) as major players of the cancer-related inflammation. J. Leukoc. Biol. 86, 1065-1073.
9. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555.
10. Ostuni, R., Kratochvill, F., Murray, P. J., Natoli, G. (2015) Macrophages and cancer: from mechanisms to therapeutic implications. Trends Immunol. 36, 229-239.
11. Bingle, L., Brown, N. J., Lewis, C. E. (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196, 254-265.
12. Lin, E. Y., Nguyen, A. V., Russell, R. G., Pollard, J. W. (2001) Colonystimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727-740.
13. Sica, A., Saccani, A., Bottazzi, B., Polentarutti, N., Vecchi, A., van Damme, J., Mantovani, A. (2000) Autocrine production of IL-10 mediates defective IL-12 production and NF-kB activation in tumor-associated macrophages. J. Immunol. 164, 762-767.
14. DeNardo, D. G., Barreto, J. B., Andreu, P., Vasquez, L., Tawfik, D., Kolhatkar, N., Coussens, L. M. (2009) CD4+ T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16, 91-102.
15. Krneta, T., Gillgrass, A., Ashkar, A. A. (2013) The influence of macrophages and the tumor microenvironment on natural killer cells. Curr. Mol. Med. 13, 68-79.
16. Wu, Y., Kuang, D. M., Pan, W. D., Wan, Y. L., Lao, X. M., Wang, D., Li, X. F., Zheng, L. (2013) Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions. Hepatology 57, 1107-1116.
17. Young, M. R., Endicott, R. A., Duffie, G. P., Wepsic, H. T. (1987) Suppressor alveolar macrophages in mice bearing metastatic Lewis lung carcinoma tumors. J. Leukoc. Biol. 42, 682-688.
18. Krneta, T., Gillgrass, A., Chew, M., Ashkar, A. A. (2015) The breast tumor microenvironment alters the phenotype and function of natural killer cells. Cell. Mol. Immunol.; (Epub ahead of print).
19. Lauber, S., Wong, S., Cutz, J. C., Tanaka, M., Barra, N., Lhoták, S., Ashkar, A., Richards, C. D. (2015) Novel function of Oncostatin M as a potent tumour-promoting agent in lung. Int. J. Cancer 136, 831-843.
20. Abe, M., Harpel, J. G., Metz, C. N., Nunes, I., Loskutoff, D. J., Rifkin, D. B. (1994) An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216, 276-284.
21. Mosser, D. M., Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
22. Varin, A., Gordon, S. (2009) Alternative activation of macrophages: immune function and cellular biology. Immunobiology 214, 630-641.
23. Alter, G., Malenfant, J. M., Altfeld, M. (2004) CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294, 15-22.
24. Chiossone, L., Chaix, J., Fuseri, N., Roth, C., Vivier, E., Walzer, T. (2009) Maturation of mouse NK cells is a 4-stage developmental program. Blood 113, 5488-5496.
25. Hayakawa, Y., Smyth, M. J. (2006) CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176, 1517-1524.
26. De Colvenaer, V., Taveirne, S., Delforche, M., De Smedt, M., Vandekerckhove, B., Taghon, T., Boon, L., Plum, J., Leclercq, G. (2011) CD27-deficient mice show normal NK-cell differentiation but impaired function upon stimulation. Immunol. Cell Biol. 89, 803-811.
27. Fabregat, I., Fernando, J., Mainez, J., Sancho, P. (2014) TGF-βeta signaling in cancer treatment. Curr. Pharm. Des. 20, 2934-2947.
28. Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R., Bottino, C., Moretta, L., Moretta, A. (2003) Transforming growth factor b1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 100, 4120-4125.
29. Trotta, R., Dal Col, J., Yu, J., Ciarlariello, D., Thomas, B., Zhang, X., Allard, J., Wei, M., Mao, H., Byrd, J. C., Perrotti, D., Caligiuri, M. A. (2008) TGF-β utilizes SMAD3 to inhibit CD16-mediated IFN-g production and antibody-dependent cellular cytotoxicity in human NK cells. J. Immunol. 181, 3784-3792.
30. Katz, L. H., Li, Y., Chen, J. S., Muñoz, N. M., Majumdar, A., Chen, J., Mishra, L. (2013) Targeting TGF-β signaling in cancer. Expert Opin. Ther. Targets 17, 743-760.
31. Mamessier, E., Sylvain, A., Thibult, M. L., Houvenaeghel, G., Jacquemier, J., Castellano, R., Gonçalves, A., André, P., Romagné, F., Thibault, G., Viens, P., Birnbaum, D., Bertucci, F., Moretta, A., Olive, D. (2011) Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J. Clin. Invest. 121, 3609-3622.
32. Wilson, E. B., El-Jawhari, J. J., Neilson, A. L., Hall, G. D., Melcher, A. A., Meade, J. L., Cook, G. P. (2011) Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity. PLoS One 6, e22842.
33. Li, H., Han, Y., Guo, Q., Zhang, M., Cao, X. (2009) Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-β1. J. Immunol. 182, 240-249.
34. Jin, J., Fu, B., Mei, X., Yue, T., Sun, R., Tian, Z., Wei, H. (2013) CD11b2CD272 NK cells are associated with the progression of lung carcinoma. PLoS One 8, e61024.
35. Fu, B., Wang, F., Sun, R., Ling, B., Tian, Z., Wei, H. (2011) CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells. Immunology 133, 350-359.
36. Poupot, M., Fournié, J. J., Poupot, R. (2008) Trogocytosis and killing of IL-4-polarized monocytes by autologous NK cells. J. Leukoc. Biol. 84, 1298-1305.